Novonesis to acquire dsm-firmenich's share of the Feed Enzyme Alliance
Novonesis has entered into an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance, taking over its sales and distribution activities in exchange for a total cash consideration of EUR 1.5 billion. The transaction follows more than 25 years of successful collaboration between the parties and aligns with Novonesis' strategic ambitions to expand its presence across the animal biosolutions value chain.
The transaction is subject to customary closing conditions.
Plesner is grateful to have advised Novonesis on this transaction, providing legal counsel on M&A and finance matters, together with Baker McKenzie and Hengeler Mueller. We extend our thank you to our colleagues for a great collaboration supporting Novonesis achieve a strategically important transaction.
Plesner's core team on the transaction included Thomas Holst Laursen, Søren Thyssen Valerius, Rasmus Mandøe Jensen, Jonathan Bell and Nanna Steenberg.